Performance measurement in cancer care : Uses and challenges

• Published in: Cancer 1998-05, Vol.82 (10), p.2016-2021
• Main Authors: LAZAR, G. S, DESCH, C. E
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Cost of Illness; Data Collection; General aspects; Health Services Misuse; Health systems. Social services; Humans; Medical Futility; Medical Oncology - economics; Medical Oncology - standards; Medical sciences; Neoplasms - economics; Neoplasms - therapy; Outcome Assessment (Health Care); Patient Satisfaction; Practice Patterns, Physicians; Program Evaluation; Public health. Hygiene; Public health. Hygiene-occupational medicine; Quality Assurance, Health Care; Quality of Life; United States
• ISSN: 0008-543X; 1097-0142
• DOI: 10.1002/(sici)1097-0142(19980515)82:10+<2016::aid-cncr7>3.0.co;2-a

Unnecessary, inappropriate, and futile care are given in all areas of health care including cancer care. Not only does such care increase costs and waste precious resources, but patients may have adverse outcomes when the wrong care is given. One of the ways to address this issue is to measure performance with the use of administrative data sets. Through performance measurement, the best providers can be chosen, providers can be rewarded on the basis of the quality of their performance, opportunities for improvement can be identified, and variation in practice can be minimized. Purchasers should take leadership role in creating data sets that will enhance, clinical performance. Specifically, purchasers should require the following from payers: 1) staging information; 2) requirements and/or incentives for proper International Classification of Diseases coding, including other important (comorbid) conditions; 3) incentives or requirements for proper data collection if the payer is using a reimbursement strategy that places the risk on the provider; and 4) a willingness to collect and report information to providers of care, with a view toward increasing quality and decreasing the costs of cancer care. Demanding better clinical performance can lead to better outcomes. Once good data is presented to patients and providers, better clinical behavior and improved cancer care systems will quickly follow.